Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

775 recalls, newest first

Class II · Moderate risk

Tacrolimus Capsules

Presence of Foreign Tablets/Capsules: One 0.5 mg Tacrolimus capsule found in a bottle of 1 mg Tacrolimus capsules.

Terminated Particulate / foreign matter Dr. Reddy's Laboratories, Inc. NDC 55111-526-01 D-0219-2024
Class III · Low risk

Anoro Ellipta

Failed Release Testing: Coarse Particle Mass for umeclidinium Out of Specification

Terminated Failed specification GlaxoSmithKline LLC NDC 0173-0869-10 D-0160-2024
Class III · Low risk

Eprontia (topiramate)

Failed Impurities/Degradation Specifications: Out of specification Impurity C (4,5-desisopropylidene topiramate) result observed during routine stability testing at 18 months.

Terminated Impurity / degradation Azurity Pharmaceuticals, Inc. NDC 52652-9001-1 D-0213-2024
Class II · Moderate risk

PAROXETINE tablets

Failed Impurities/Degradation Specifications-Manufacturer Apotex Inc. recalling lots due to Out of specification results for the excipient Amadori Glucose adduct of Paroxetine

Terminated Impurity / degradation Golden State Medical Supply Inc. NDC 60429-737-30 D-0130-2024
Class II · Moderate risk

PAROXETINE tablets

Failed Impurities/Degradation Specifications-Manufacturer Apotex Inc. recalling lots due to Out of specification results for the excipient Amadori Glucose adduct of Paroxetine

Terminated Impurity / degradation Golden State Medical Supply Inc. NDC 60429-735-90 D-0129-2024
Class II · Moderate risk

PAROXETINE tablets

Failed Impurities/Degradation Specifications-Manufacturer Apotex Inc. recalling lots due to Out of specification results for the excipient Amadori Glucose adduct of Paroxetine

Terminated Impurity / degradation Golden State Medical Supply Inc. NDC 60429-734-30 D-0128-2024

Recalls by year